Fundraising FoxSoftBank Vision Fund — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques.
AI & Machine LearningBiotechDeep TechCambridge, US
Donald A. Bergstrom(Executive Officer)inSanjiv K. Patel(Director, President and Chief Executive Officer)inSekar Kathiresan(Director)Douglas S. Ingram(Director)Mark Murcko(Director)Laura Shawver(Director)
Co-investorsCommonweal VenturesEcoR1 CapitalForesite CapitalNat TurnerNextech InvestCurie.Bio+2 more
Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.
BiotechHealthtechMedical DevicesNew York, US
Clive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)Clive Meanwell(Founder)
Co-investorsAlpha Wave GlobalARCH Venture PartnersF-Prime CapitalGV (Google Ventures)RA CapitalViking Global+5 more
Wiz provides cloud security platform that identifies and removes critical risks across multi-cloud environments.
Cloud ComputingCybersecurityEnterprise SoftwareNew York, US
Assaf Rappaport(Founder)inAmi Luttwak(Founder)inRoy Reznik(Founder)inYinon Costica(Founder)inDali Rajic(President and COO)inAdi Leist Sharon(Chief Business Officer)in
Co-investorsAglae VenturesAndreessen HorowitzaVentureBond Capital ManagementCraft VenturesCyberstarts+20 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.